|
Symbol Name ID |
Tpm1
tropomyosin 1, alpha MGI:98809 |
Excel File
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| \Slc4a3tm1Ges/\Slc4a3tm1Ges \Tg(Myh6-Tpm1*E180G)57Dfw/0 involves: 129X1/SvJ * FVB/N |
abnormal calcium ion homeostasis | J:171021 |
| abnormal cardiac muscle relaxation | J:171021 | |
| abnormal heart rate | J:171021 | |
| cardiac hypertrophy | J:171021 | |
| congestive heart failure | J:171021 | |
| decreased cardiac muscle contractility | J:171021 | |
| decreased heart rate | J:171021 | |
| decreased left ventricle systolic pressure | J:171021 | |
| decreased locomotor activity | J:171021 | |
| decreased mean systemic arterial blood pressure | J:171021 | |
| edema | J:171021 | |
| increased lung weight | J:171021 | |
| premature death | J:171021 | |
| respiratory distress | J:171021 | |
| rough coat | J:171021 | |
| \Tln2em1Clo/\Tln2+ \Tpm1em1Clo/\Tpm1+ involves: C57BL/6 * DBA/2 |
atrial septal defect | J:320916 |
| embryonic lethality between implantation and placentation, incomplete penetrance | J:320916 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 03/25/2025 MGI 6.24 |
|
|
|
||
Analysis Tools